Abstract
Background Besides Covid-19, SARS-CoV-2 infection has been associated with Multiple Inflammatory Syndrome in children (MIS-C). However, a unique presentation of a transient form of hepatitis in pediatric age group occurring subsequent to the asymptomatic SARS-CoV-2 infection is yet to be reported. Presently the clinical presentation, temporal association and viral parameters of the cases of CAH-C contrasting to MIS-C hepatitis, have been reported
Methods As a retrospective and follow up observational study we reviewed all pediatric patients presenting with acute hepatitis. There were increased numbers cases with features of hepatitis in pediatric group during the second wave of SARS CoV-2 infections, where 25 children or adolescents developing sudden onset of acute hepatitis without prior liver disease or familiar etiology of acute hepatitis. They had history of COVID-19 RT-PCR positivity within 3-6 weeks or a retrospectively proven Covid-19 infection with high titer SARS CoV-2 antibodies. In contrast a group of 8 COVID-19 patients had features of MIS-C with protracted illness and multiple organ involvement.
Results Among 33 paediatric patients presented with hepatitis, 25 patients had features of CAH-C, They had symptoms of hepatitis only without typical Covid-19 presentations. These patients had normal to borderline increase in inflammatory markers with uneventful recovery following supportive treatment. Whereas remaining 8 MIS-C pateints with hepatitis had elvated level of inflammatory markers and required admission in critical care with a mortality of 37.5% ( 3/ 8).
Conclusion With the emergence of newer variants of concern(VOC) including the Delta variant which has now spread to more than 60 countries and was responsible for the massive wave of Covid-19 across India, with changing presentations where CAH-C may be one of them. Such new entities need to be identified and differentiated from other emerging syndromes in children for appropriate management.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external grant has been used for the study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the IRB and the institutional human ethics committee, Bundelkhand Medical College, Sagar registration number ECR/1252/Inst/MP/2019. The follow-up and analysis work was performed after the ethical approval was granted by the institutional human ethics committee of our institute. Wide reference letter IEC/BMC/80/21.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Grant support: NA
This revised version had incorporated changes in naming of the entity CAH-C, making them more specific. Some parts of Introduction and discussion have been rewritten to present a more clear picture about the study participants based on the reviews and queries of readers. Some redundant sentences have been removed from where they reappeared. One important landmark reference has been added. Conclusion has been rewritten to make it more meaningful in current context. Some figures i.e. figure 2,3, 4 and 5 have been improved based on reader feedback.
Data Availability
All data related to the manuscript is available with the author.
https://main.icmr.nic.in/sites/default/files/press_realease_files/ICMR_PR_IgG_Elisa_30052020.pdf
